Search Results

Containing any of the words

Only of the type

A phase 3, multi-center, open-label, randomized study of oral ABL001 versus bosutinib in patients with Chronic Myelogenous Leukemia in chronic phase (CML-CP), previously treated with 2 or more tyrosine kinase inhibitors Drug Clinical Trial

SFDA Monitors 274 Violations During 4,891 Inspection Tours in August News

SFDA Monitors 291 Violations During 4,677 Inspection Tours in June News

"A multicenter, multinational, prospective, interventional,single-arm, Phase IV study evaluating the clinicalefficacy and safety of 26 weeks of treatment with insulin glargine 300 U/mL (Gla-300) in patients with Type 2 diabetes mellitus uncontrolled on basal insulin" Drug Clinical Trial

(SG-2206-393-H-P) MiniMed™ 600 and 700 series insulin pump Battery Cap Medical Report

Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC): A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188 (Purified Poloxamer 188) Injection in Subjects With Sickle Cell Disease Experiencing Vaso Occlusive Crisis Drug Clinical Trial

Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC): A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188 (Purified Poloxamer 188) Injection in Subjects With Sickle Cell Disease Experiencing Vaso Occlusive Crisis Drug Clinical Trial

Empowering Health Care Innovation: Saudi Arabia’s Pioneering Approach to Point-of-Care Medical Device Manufacturing Scientific Magazines and articles

INTERFERON-INDUCED PROLONGED BIOCHEMICAL RESPONSE REDUCES HEPATOCARCINOGENESIS IN HEPATITIS C VIRUS INFECTION Awareness Article

U.S. FDA Takes Action to Stop the Marketing of Unapproved Injectable Drugs Containing Colchicine Warnings